Literature DB >> 26432041

Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer.

Devarati Mitra1, Ann H Klopp2, Akila N Viswanathan3.   

Abstract

A large number of studies have looked at the role of radiation therapy in the treatment of endometrial cancer. One particular radiation strategy in common practice is the use of adjuvant external beam (EB) radiotherapy followed by vaginal brachytherapy (VB). While the addition of VB to EB provides a theoretical benefit of a localized boost with higher focused dose to an area of potentially high recurrence risk, a randomized clinical trial to compare outcomes and toxicities of EB+VB vs. EB alone is lacking. The goal of this review is to present the current data for and against the use of this combined radiation modality and to provide some preliminary evidence regarding which patient populations may be most likely to benefit.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; External beam radiation therapy; Vaginal brachytherapy

Mesh:

Year:  2015        PMID: 26432041     DOI: 10.1016/j.ygyno.2015.09.084

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  [Improved overall survival with brachytherapy in stage III endometrial cancer].

Authors:  Peter Niehoff
Journal:  Strahlenther Onkol       Date:  2018-10       Impact factor: 3.621

2.  MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.

Authors:  Sophia C Kamran; Matthias M Manuel; Paul Catalano; Linda Cho; Antonio L Damato; Larissa J Lee; Ehud J Schmidt; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2017-08-17       Impact factor: 2.362

3.  Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy.

Authors:  Yurday Ozdemir; Yemliha Dolek; Cem Onal
Journal:  J Contemp Brachytherapy       Date:  2017-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.